Albinism: Clinical Trials

9 trials for Albinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 2 unknown, 1 active not recruiting. 9 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 4, Terminated 2, Unknown 2, Active not recruiting 1

Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Korean Translation and Validation of the K-HEPI in NYC
Nurses Taking On Readiness Measures (N- TORM) - Disaster, Vulnerable Populations
Not applicableCompletedHunter College of City University of New York4002023-07-132024-08-15
Functional Tests to Resolve Unsolved Rare Diseases. Rares.
Ex-vivo approach concerning 25 patients, In-vitro approach concerning 25 patients - Intellectual Disability, Rubinstein-Taybi Syndrome
Not applicableUnknownUniversity Hospital, Bordeaux502023-01-302024-02-21
Nurses Taking On Readiness Measures - Mercer County, New Jersey
Nurses Taking On Readiness Measures (N-TORM) - Disaster, Vulnerable Populations
Not applicableCompletedHunter College of City University of New York312022-03-072024-12-05
Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population
Genetic analysis, Ophthalmologic exam - Fovea Plana, Albinism
Not applicableCompletedFondation Ophtalmologique Adolphe de Rothschild202020-12-172026-01-06
The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism
Lutein plus Zeaxanthin, Placebo - Ocular Albinism (OA), Oculocutaneous Albinism (OCA)
Not applicableCompletedJohns Hopkins University102014-11-012018-12-28
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan - SCID, Omenn's Syndrome
Not applicableActive not recruitingMasonic Cancer Center, University of Minnesota572012-09-042026-06-17
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Alefacept - Thalassemia, Sickle Cell Disease
Not applicableTerminatedEmory University32010-09-012017-07-27
Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
anti-thymocyte globulin, busulfan, cyclophosphamide - Chediak-Higashi Syndrome, Graft Versus Host Disease
Not applicableUnknownFairview University Medical Center402000-03-012005-06-24
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
anti-thymocyte globulin, busulfan, cyclophosphamide - Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome
Not applicableTerminatedFairview University Medical Center2000-03-012009-10-15

Narrower conditions

Chediak-Higashi Syndrome (4)  ·  Granulomatous Disease, Chronic (3)  ·  Lymphohistiocytosis, Hemophagocytic (3)  ·  Lymphoproliferative Disorders (3)  ·  Wiskott-Aldrich Syndrome (3)  ·  Common Variable Immunodeficiency (2)  ·  Communicable Diseases (2)  ·  Emergencies (2)  ·  Genetic Diseases, Inborn (2)  ·  Graft vs Host Disease (2)  ·  Hematologic Diseases (2)  ·  Histiocytosis (2)  ·  Histiocytosis, Langerhans-Cell (2)  ·  Immune System Diseases (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Eye Diseases, Hereditary (9)  ·  Metabolic Diseases (8)  ·  Nutritional and Metabolic Diseases (8)  ·  Eye Diseases (7)  ·  Genetic Diseases, Inborn (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Disease Attributes (6)  ·  Pathologic Processes (6)  ·  Skin Diseases (6)  ·  Skin Diseases, Genetic (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Amino Acid Metabolism, Inborn Errors (5)  ·  Hypopigmentation (5)

Interventions

Busulfan (3)  ·  Cyclophosphamide (3)  ·  Antilymphocyte Serum (2)  ·  Cyclosporine (2)  ·  Etoposide (2)  ·  Methotrexate (2)  ·  Alefacept (1)  ·  Alemtuzumab (1)  ·  Filgrastim (1)  ·  Genetic Testing (1)  ·  Lutein (1)  ·  Melphalan (1)  ·  Mesna (1)  ·  Methylprednisolone (1)  ·  Prednisone (1)

Sponsors

Fairview University Medical Center (2)  ·  Hunter College of City University of New York (2)  ·  Emory University (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Johns Hopkins University (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  University Hospital, Bordeaux (1)

Countries

United States (7)  ·  France (2)

Top investigators

K. Scott Baker (2)  ·  John Horan, MD (1)  ·  Mary E. Frey (1)  ·  Meera Srikanthan, MD (1)  ·  Neil Bressler, MD (1)  ·  Tara Heagele, PhD, RN (1)  ·  Tara N Heagele, PhD (1)

Results publications

PMID 26095669, PMID 40546025